Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

Old API Wind-down Ltd - Ordinary Shares > No Bloom and Burton Conference this year for ARLZ
View:
Post by kuatolives on Apr 30, 2017 10:42am

No Bloom and Burton Conference this year for ARLZ

Wonder why. Actually, no I don't.
Comment by biggerr on May 03, 2017 12:00pm
Comment by biggerr on May 03, 2017 2:15pm
the more good news come out the more shorts get desperate and double down on their shorts hoping to force everybody to sell, hah
Comment by kuatolives on May 03, 2017 2:33pm
Plumbing new depths....
Comment by biggerr on May 03, 2017 3:18pm
as you can see ARZ is targeting guys with the MI(heart attack) and PAD for Zontivity. Patients who just had the MI could be a good target since they don't have other drugs prescribed yet, why not try Zon
Comment by GoldenDilemma on May 03, 2017 3:58pm
biggerr, how under water are you in the name and why are you having a one way conversation... 
Comment by biggerr on May 03, 2017 7:41pm
ARLZ up 3.5% in AH, I guess shorts can't short in the AH, ha
Comment by biggerr on May 04, 2017 1:31pm
I didn't know that Zon could be used for 9 mil. diabetic smokers in addition to 15 mil. MI/PAD patients according to the AGM presentation
Comment by biggerr on May 04, 2017 4:17pm
just like my aunt Edna 
Old API Wind-down Ltd - Ordinary Shares
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities